24H | Eli Lilly Stock Jumps Nearly 2% as Lilly Inks Deal with Innovent to Speed Up Early Drug Development
Eli Lilly is paying $350 million upfront to collaborate with Chinese biotech Innovent Biologics Inc. in developing new treatments for cancer and immune disorders, a further vote of confidence for the innovation capabilities of the country’s drugmakers.
Shares of Eli Lilly rose 1.83% in overnight trading.
Under the agreement, which marks the seventh collaboration between the two firms, Innovent will lead the development of programs from concept through the completion of phase II clinical trials in China. Lilly will have an exclusive license to develop and commercialize the products outside of Greater China.
"This alliance moves beyond traditional licensing to create a seamless, end-to-end innovation ecosystem," Innovent CEO Michael Yu said in a statement on Sunday, adding that it also validates Innovent's research and development capabilities.
Innovent has also partnered with Lilly on projects such as the weight loss drug mazdutide.
In addition to the $8.5 billion in payments tied to developmental, regulatory and commercial milestones, Innovent will also be eligible for royalties on net sales of products outside of Greater China.
Related Articles
National Debt Bomb Ignited? Musk Warns U.S. Will Be 1000% Bankrupt Without AI
TradingKey - Tesla (TSLA) CEO Elon Musk recently issued another warning regarding the rapidly ballooning U.S. national debt. He stated clearly that without artificial intelligence and robotics, the United States will inevitably head toward fiscal bankruptcy.
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).
Why Sanae Takaichi Winning Japan’s Diet Election Led to a Surge in Japanese Stock Indices？
TradingKey - Reports indicate that the ruling coalition led by Japanese Prime Minister Sanae Takaichi has secured a single-party majority in the parliamentary elections held on Sunday (February 8). Following the news, the yen weakened slightly, while the Nikkei Index surpassed 57,000 for the first t
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
